John Newman Profile - Canaccord Genuity Analyst
844 Followers
John Newman's Stock Coverage
| PBLSParabilis Medicines, Inc. | Nov 13, 2026 | BUY | Reiterated | $39.00 | 2Ratings | -8.80% | ||
| CADLCandel Therapeutics | Nov 13, 2026 | BUY | Reiterated | $13.00 | 14Ratings | +32.66% | ||
| BBOTBridgeBio Oncology Therapeutics | Nov 12, 2026 | BUY | Reiterated | $20.00 | 6Ratings | -59.12% | ||
| TYRATyra Bioscience | Nov 11, 2026 | BUY | Reiterated | $50.00 | 18Ratings | -29.18% | ||
| XNCRXencor | Nov 10, 2026 | BUY | Reiterated | $40.00 | 15Ratings | +54.09% | ||
| TNGXTango Therapeutics | Nov 10, 2026 | BUY | Reiterated | $46.00 | 17Ratings | -1.10% | ||
| REGNRegeneron | Nov 10, 2026 | BUY | Reiterated | $1,175.00 | 121Ratings | +10.04% | ||
| DCTHDelcath Systems | Nov 10, 2026 | BUY | Reiterated | $27.00 | 32Ratings | +38.98% | ||
| CMPXCompass Therapeutics | Nov 10, 2026 | BUY | Reiterated | $7.00 | 18Ratings | -60.26% | ||
| ATRAAtara Biotherapeutics | Nov 10, 2026 | BUY | Reiterated | $13.00 | 94Ratings | -30.58% |
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed. See how TipRanks ranks experts and calculates performance.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >John Newman activity FAQ
What is the performance of John Newman's recommendations?
The percentage of profitable recommendations made by John Newman is 37.63%, and the average return per transaction is -6.60%.
What stocks does John Newman cover?
John Newman mostly covers Candel Therapeutics, Parabilis Medicines, Inc., BridgeBio Oncology Therapeutics stocks.
What was John Newman's most profitable rating?
John Newman’s most profitable rating was a buy on IMGN stock on Mar 01, 2023. The return on the trade was 630.00%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here
